Literature DB >> 24879725

Ureteric access sheath aided insertion of resonance metal ureteric stent.

Matthew Winter1, Stephen Strahan1, Michael Wines1.   

Abstract

Ureteral obstruction caused by malignancy is a challenging and often complicated problem for urologists. We present a novel technique of ureteric access sheath aided insertion of a Resonance metal ureteric stent in the setting of a difficult obstruction. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24879725      PMCID: PMC4039898          DOI: 10.1136/bcr-2013-203350

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

1.  Metal ureteral stent for benign and malignant ureteral obstruction.

Authors:  Aaron D Benson; Eric R Taylor; Bradley F Schwartz
Journal:  J Urol       Date:  2011-04-17       Impact factor: 7.450

2.  Cost analysis of metallic ureteral stents with 12 months of follow-up.

Authors:  Eric R Taylor; Aaron D Benson; Bradley F Schwartz
Journal:  J Endourol       Date:  2012-04-17       Impact factor: 2.942

3.  Metallic stent in the treatment of ureteral obstruction: experience of single institute.

Authors:  Chien-Chang Li; Jian-Ri Li; Li-Hua Huang; Siu-Wan Hung; Cheng-Kuang Yang; Shiang-Shian Wang; Chuan-Su Chen; Yen-Chuan Ou; Hao-Chung Ho; Chung-Kuang Su; Wen-Ming Chen; Chen-Li Cheng; Chi-Rei Yang; Kun-Yuan Chiu
Journal:  J Chin Med Assoc       Date:  2011-10-20       Impact factor: 2.743

Review 4.  Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.

Authors:  Evangelos N Liatsikos; Dimitrios Karnabatidis; Konstantinos Katsanos; Panagiotis Kallidonis; Paraskevi Katsakiori; George C Kagadis; Nikolaos Christeas; Zafiria Papathanassiou; Petros Perimenis; Dimitrios Siablis
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

  4 in total
  1 in total

Review 1.  Palliative management of malignant upper urinary tract obstruction.

Authors:  P Sountoulides; I Mykoniatis; N Dimasis
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.